BUHLMANN News | Buhlmann Diagnostics Corp | Newsletter | Tradeshow

BUHLMANN News

Quantum Blue®Anti-Infliximab and Anti-Adalimumab Tests Now Available

New Quantum Blue® TDM Assays BÜHLMANN is proud to introduce Quantum Blue® Anti-Infliximab (RUO) and Anti-Adalimumab (RUO) to the TDM ...
Read More

Flow CAST- Assay Overview Video

Flow CAST®: Research Use Only in the US. Not for diagnostic procedures. Health Canada License:101781 BÜHLMANN Flow CAST® and Basophil ...
Read More

Visit BUHLMANN at CDDW 2020

Canadian Digestive Diseases Week (CDDW) 2020 BUHLMANN Diagnostics Corp Booth: #13 Feb 28 - Mar 1, 2020 | Fairmont Queen ...
Read More

IBDoc Key Literature List

IBDoc® Publications View a compilation of BÜHLMANN IBDoc® calprotectin citations from a wide variety of interesting publications, studies, and posters ...
Read More

100 BÜHLMANN Calprotectin Publications

BÜHLMANN launched its first fecal calprotectin assay over 10 years ago and since then has developed into THE CALPROTECTIN COMPANY ...
Read More

IBDoc® Talk #2

IBDoc® IBDoc® is the first self-testing application for fecal calprotectin in IBD patients that involves three easy steps. Based on ...
Read More

BUHLMANN Debriefing- EuroMedLab 2019

BÜHLMANN Educational Workshop at EuroMedLab 2019 The BÜHLMANN Educational Workshop at EuroMedLab 2019, focused on optimizing workflow for fecal calprotectin ...
Read More

Visit BUHLMANN at Meeting of the Minds 2019

Meeting of the Minds 2019 BUHLMANN Diagnostics Corp Stop by our Booth! Nov 15-16, 2019 | Ritz Carlton Hotel ...
Read More